IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in IGC Pharma, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- 0 vs. Q1 2022
- Shares held
- 3.27M
- −910.5K (−21.8%) vs. Q1 2022
- Total value
- $1.73M
- −$2.24M (−56.3%) vs. Q1 2022
- New holders
- 4
- 13 more added
- Sold out
- 4
- 2 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $1.41M |
| Q1 2026 | 35 | $1.14M |
| Q4 2025 | 30 | $1.36M |
| Q3 2025 | 35 | $2.27M |
| Q2 2025 | 28 | $929.4K |
| Q1 2025 | 25 | $814.9K |
| Q4 2024 | 30 | $954.3K |
| Q3 2024 | 23 | $1.19M |
| Q2 2024 | 25 | $1.11M |
| Q1 2024 | 25 | $943.4K |
| Q4 2023 | 25 | $691.3K |
| Q3 2023 | 27 | $1.01M |
| Q2 2023 | 23 | $827.5K |
| Q1 2023 | 23 | $917.6K |
| Q4 2022 | 26 | $937.3K |
| Q3 2022 | 26 | $1.31M |
| Q2 2022 | 29 | $1.73M |
| Q1 2022 | 29 | $3.97M |
| Q4 2021 | 29 | $6.07M |
| Q3 2021 | 32 | $7.90M |
| Q2 2021 | 29 | $7.90M |
| Q1 2021 | 29 | $7.97M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding IGC Pharma, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 744,164 | $394.0K | 0.00% | −114,622−13.3% | Reduced |
| Vanguard Group Inc | 645,799 | $343.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 302,884 | $160.0K | 0.00% | +10,395+3.6% | Added |
| Renaissance Technologies LLC | 217,749 | $115.0K | 0.00% | +217,749 | New |
| State Street Corp | 184,107 | $98.0K | 0.00% | +5,400+3.0% | Added |
| Susquehanna International Group, LLP | 178,439 | $94.0K | 0.00% | +58,462+48.7% | Added |
| Bridgeway Capital Management, LLC | 139,000 | $74.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 129,190 | $69.0K | 0.00% | +119,183+1,191.0% | Added |
| Dearborn Partners LLC | 125,026 | $66.0K | 0.00% | +28,125+29.0% | Added |
| Vident Investment Advisory, LLC | 108,431 | $57.0K | 0.00% | +4,420+4.2% | Added |
| Davy Global Fund Management Ltd | 102,133 | $54.0K | 0.01% | +4,898+5.0% | Added |
| Goldman Sachs Group Inc | 65,494 | $35.0K | 0.00% | +110.0% | Added |
| Northern Trust Corp | 63,328 | $34.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 48,281 | $26.0K | 0.00% | +36,290+302.6% | Added |
| Commonwealth Equity Services, LLC | 50,250 | $26.0K | 0.00% | +50,250 | New |
| Virtu Financial LLC | 44,970 | $24.0K | 0.00% | +22,262+98.0% | Added |
| Truist Financial Corp | 36,667 | $19.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 31,053 | $16.0K | 0.00% | +4,255+15.9% | Added |
| HRT Financial LP | 19,694 | $10.0K | 0.00% | +19,694 | New |
| UBS Group AG | 16,179 | $8.00K | 0.00% | +3,229+24.9% | Added |
| ExodusPoint Capital Management, LP | 13,049 | $7.00K | 0.00% | +13,049 | New |
| Geneos Wealth Management Inc. | 3,200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,411 | $1.00K | 0.00% | −38−2.6% | Reduced |
| Toronto Dominion Bank | 1,106 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 297 | $0 | 0.00% | +24+8.8% | Added |
| Evermay Wealth Management LLC | 30 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 796 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 232 | $0 | 0.00% | 00.0% | Unchanged |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −1,377,257−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,436−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,364−100.0% | Sold out |
| Fairfield Financial Advisors, LTD | 0 | $0 | 0.00% | −500−100.0% | Sold out |